Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC) Meeting Abstract

  

Authors:	O'Cearbhaill, R. E.; McMeekin, D. S.; Mantia-Smaldone, G.; Gunderson, C.; Sabbatini, P.; Cattaruzza, F.; Fischer, M.; Kapoun, A. M.; Xu, L.; Dupont, J.; Brachmann, R. K.; Farooki, A.; Moore, K. N.
Abstract Title:	Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and paclitaxel (P) in recurrent platinum-sensitive ovarian cancer (OC)
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	117s
Language:	English
ACCESSION:	WOS:000404665403114
DOI:	10.1200/JCO.2016.34.15_suppl.2515
PROVIDER:	wos
Notes:	Meeting Abstract: 2515 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/155045